会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • DISULFIDE CYCLIC POLYPEPTIDES FOR THE TREATMENT OF HEART FAILURE
    • 用于治疗心力衰竭的解决循环多糖
    • WO2015013167A1
    • 2015-01-29
    • PCT/US2014/047375
    • 2014-07-21
    • NOVARTIS AGZECRI, FrédéricGROSCHE, PhilippYASOSHIMA, KayoZHAO, HongjuanYUAN, Jun
    • ZECRI, FrédéricGROSCHE, PhilippYASOSHIMA, KayoZHAO, HongjuanYUAN, Jun
    • C07K14/47A61K38/17A61P9/04
    • C07K7/08A61K38/08A61K38/10A61K45/06C07K7/06C07K14/47
    • The invention provides a synthetic polypeptide of Formula I': X1-R-P-R-X5-X6-X7-K-X9-P-X11-X12-X13 or an amide, an ester, a salt or a bioconjugate thereof, wherein X1, X5, X6, X7, X9 and X11 to X13 are defined herein. The polypeptides and bioconjugates are agonist of the APJ receptor. The invention also relates to a method for manufacturing the polypeptides or bioconjugates of the invention, and its therapeutic uses such as treatment or prevention of acute decompensated heart failure (ADHF), chronic heart failure, pulmonary hypertension, atrial fibrillation, Brugada syndrome, ventricular tachycardia, atherosclerosis, hypertension, restenosis, ischemic cardiovascular diseases, cardiomyopathy, cardiac fibrosis, arrhythmia, water retention, diabetes (including gestational diabetes), obesity, peripheral arterial disease, cerebrovascular accidents, transient ischemic attacks, traumatic brain injuries, amyotrophic lateral sclerosis, burn injuries (including sunburn) and preeclampsia. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    • 本发明提供式I'的合成多肽:X1-RPR-X5-X6-X7-K-X9-P-X11-X12-X13或其酰胺,酯,盐或生物缀合物,其中X1,X5 ,X6,X7,X9,X11〜X13。 多肽和生物缀合物是APJ受体的激动剂。 本发明还涉及制备本发明的多肽或生物缀合物的方法及其治疗用途,例如治疗或预防急性失代偿性心力衰竭(ADHF),慢性心力衰竭,肺动脉高压,心房颤动,Brugada综合征,室性心动过速 ,动脉粥样硬化,高血压,再狭窄,缺血性心血管疾病,心肌病,心脏纤维化,心律失常,保水,糖尿病(包括妊娠糖尿病),肥胖,外周动脉疾病,脑血管意外,短暂性脑缺血发作,创伤性脑损伤,肌萎缩性侧索硬化,烧伤 受伤(包括晒伤)和先兆子痫。 本发明还提供药理活性剂和药物组合物的组合。
    • 7. 发明申请
    • CYCLIC APELIN DERIVATIVES FOR THE TREATMENT OF HEART FAILURE
    • 用于治疗心力衰竭的循环APELIN衍生物
    • WO2015013165A1
    • 2015-01-29
    • PCT/US2014/047372
    • 2014-07-21
    • NOVARTIS AGZECRI, FrédéricGROSCHE, PhilippYASOSHIMA, KayoZHAO, HongjuanYUAN, Jun
    • ZECRI, FrédéricGROSCHE, PhilippYASOSHIMA, KayoZHAO, HongjuanYUAN, Jun
    • C07K14/47A61K38/17A61P9/04
    • C07K14/47A61K38/10A61K38/1709A61K45/06A61K47/643A61K47/6811
    • The invention provides a synthetic polypeptide of Formula I': X1-R-X3-R-L-X6-X7-K-X9-P-X11-X12-X13 or an amide, an ester, a salt thereof, or a bioconjugate thereof, wherein X1, X3, X6, X7, X9, X11, X12 and X13 are defined herein. The polypeptides and bioconjugates are agonist of the APJ receptor. The invention also relates to a method for manufacturing the polypeptides and bioconjugates of the invention, and its therapeutic uses such as treatment or prevention of acute decompensated heart failure (ADHF), chronic heart failure, pulmonary hypertension, atrial fibrillation, Brugada syndrome, ventricular tachycardia, atherosclerosis, hypertension, restenosis, ischemic cardiovascular diseases, cardiomyopathy, cardiac fibrosis, arrhythmia, water retention, diabetes (including gestational diabetes), obesity, peripheral arterial disease, cerebrovascular accidents, transient ischemic attacks, traumatic brain injuries, amyotrophic lateral sclerosis, burn injuries (including sunburn) and preeclampsia. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    • 本发明提供式I'的合成多肽:X1-R-X3-RL-X6-X7-K-X9-P-X11-X12-X13或其酰胺,酯,其盐或其生物缀合物, 其中X1,X3,X6,X7,X9,X11,X12和X13在本文中定义。 多肽和生物缀合物是APJ受体的激动剂。 本发明还涉及本发明的多肽和生物缀合物的制备方法及其治疗用途,例如治疗或预防急性失代偿性心力衰竭(ADHF),慢性心力衰竭,肺动脉高压,心房颤动,Brugada综合征,室性心动过速 ,动脉粥样硬化,高血压,再狭窄,缺血性心血管疾病,心肌病,心脏纤维化,心律失常,保水,糖尿病(包括妊娠糖尿病),肥胖,外周动脉疾病,脑血管意外,短暂性脑缺血发作,创伤性脑损伤,肌萎缩性侧索硬化,烧伤 受伤(包括晒伤)和先兆子痫。 本发明还提供药理活性剂和药物组合物的组合。
    • 8. 发明申请
    • SYNTHETIC LINEAR APELIN MIMETICS FOR THE TREATMENT OF HEART FAILURE
    • 用于治疗心脏衰竭的合成线性APELINMIMT
    • WO2014081702A2
    • 2014-05-30
    • PCT/US2013/070742
    • 2013-11-19
    • NOVARTIS AGZECRI, FrédéricYASOSHIMA, KayoGROSCHE, PhilippYUAN, JunZHAO, Hongjuan
    • ZECRI, FrédéricYASOSHIMA, KayoGROSCHE, PhilippYUAN, JunZHAO, Hongjuan
    • A61K38/00C07K14/00
    • C07K14/765A61K38/385A61K45/06C07K14/47A61K38/1709A61K2300/00
    • The invention provides a synthetic polypeptide of Formula I': or an amide, an ester or a salt thereof, or a bioconjugate thereof, wherein X1, X2, X3, X5, X6, X7, X8, X9, X10, X11, X12 and X13 are defined herein. The polypeptides or bioconjugates thereof are agonist of the APJ receptor. The invention also relates to a method for manufacturing the polypeptides or bioconjugates of the invention, and its therapeutic uses such as treatment or prevention of acute decompensated heart failure (ADHF), chronic heart failure, pulmonary hypertension, atrial fibrillation, Brugada syndrome, ventricular tachycardia, atherosclerosis, hypertension, restenosis, ischemic cardiovascular diseases, cardiomyopathy, cardiac fibrosis, arrhythmia, water retention, diabetes (including gestational diabetes), obesity, peripheral arterial disease, cerebrovascular accidents, transient ischemic attacks, traumatic brain injuries, amyotrophic lateral sclerosis, burn injuries (including sunburn) and preeclampsia. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    • 本发明提供式I'的合成多肽:或其酰胺,酯或其盐或其生物缀合物,其中X 1,X 2,X 3,X 5,X 6,X 7,X 8,X 9,X 10,X 11,X 12和 X13在本文中定义。 多肽或其生物缀合物是APJ受体的激动剂。 本发明还涉及制备本发明的多肽或生物缀合物的方法及其治疗用途,例如治疗或预防急性失代偿性心力衰竭(ADHF),慢性心力衰竭,肺动脉高压,心房颤动,Brugada综合征,室性心动过速 ,动脉粥样硬化,高血压,再狭窄,缺血性心血管疾病,心肌病,心脏纤维化,心律失常,保水,糖尿病(包括妊娠糖尿病),肥胖,外周动脉疾病,脑血管意外,短暂性脑缺血发作,创伤性脑损伤,肌萎缩性侧索硬化,烧伤 受伤(包括晒伤)和先兆子痫。 本发明还提供药理活性剂和药物组合物的组合。